近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Maria Woolley, Colin Jones, Joanne Davies, Usha Rao, David Ewins, Sunil Nair, Frank Joseph. Type 1 diabetes and pregnancy: a phenomenological study of women’s first experiences. Practical Diabetes Vol. 31 (1) 2015 January/February Khan M, Joseph F. Adipose tissue and adipokines: the association with and application of adipokines in obesity. Scientifica. 2014;2014:328592. doi: 10.1155/2014/328592. Epub 2014 Sep 17. Review Steve Chaplin, Claire McCourt, Frank Joseph Xigduo: dapagliflozin plus metformin for T2DM. Prescriber Volume 25 Issue 19 (5 October 2014) (p 36-38) Deepa Beeharry, Franklin Joseph, David Ewins & Sunil Nair Dietary Management of Diabetic Chronic Kidney Disease: Current Nutrition Reports September 2014, Volume 3 :10.1007/s13668-014-0093-3 Joseph F. ‘Just do it, ’cos I’ve got your back!’ Diabetes care: the West Cheshire Way. Practical Diabetes 2014; 31(4): 169–172 Buckley JP, Mellor DD, Morris M, Joseph F. Standing-based office work shows encouraging signs of attenuating post-prandial glycaemic excursion.Occup Environ Med. 2014 Feb;71(2):109-11. Epub 2013 Dec 2. BEACON Trial Investigators. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013 Dec 26;369(26):2492-503. Epub 2013 Nov 9. UK Dopamine Agonist Valvulopathy Group. A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists. J Clin Endocrinol Metab. 2014 Jan;99(1):90-6. Epub 2013 Dec 20. UK Acromegaly Register Study Group (UKAR-3).Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists. Clin Endocrinol (Oxf). 2013 Nov;79(5):689-99. Epub 2013 Apr 24. Joseph F. Editorial: Change is the only constant: How do we make the best therapeutic decisions in the face of ever-evolving diabetes care? Supplement to Diabetes Digest Volume 12 Number 4 2013 Steve Chaplin, Frank Joseph Lixisenatide (Lyxumia): new GLP‐1 mimetic for type 2 diabetes Prescriber Volume 25 Issue 6 (19 March 2014) (p 14-16) Steve Chaplin, Frank Joseph Insulin degludec (Tresiba): new ultra long‐acting basal insulin. Prescriber Volume 24 Issue 17 (5 September 2013) (p 13-18) Bennett K, Joseph F. Diabetes requiring insulin – recent developments in management. Prescriber. Volume 24 Issue 11 (5 June 2013) (p 21-29) Joseph F. Treating to target: Comparing analogue and human basal insulins. Supplement to Diabetes Digest Vol 12 No 2 2013 R Seys Llewellyn, F Joseph, D Ewins, N Goenka, E Domanne, A Franks. BMJ 2012;344:e2122 (Published 21 March 2012) Gardner CJ, Irwin AJ, Daousi C, McFarlane IA, Joseph F , Bell JD, Thomas EL, Adams VL, Kemp GJ, Cuthbertson DJ. Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study. Eur J Endocrinol. 2012 Jun;166(6):993-1002. Epub 2012 Mar 20 Sharma D, Morrison G, Joseph F, Purewal TS, Weston PJ. The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis. Diabetologia. 2011 Nov;54(11):2768-70. Epub 2011 Aug 14. Jones R, Jones J, Causer J, Ewins D, Goenka N, Joseph F. Yew tree poisoning: a near-fatal lesson from history. Clin Med. 2011 Apr;11(2):173-5. Joseph F, Reeve-Fowkes A, Ewins D, Goenka N. Medicine at the sharp end. Clin Med. 2009 Dec;9(6):630-1 S Nair, F Joseph, D Ewins, J Wilding and N Goenka. From history to reality: sodium glucose co-transporter 2 inhibitors – a novel therapy for type 2 diabetes mellitus. Practical Diabetes International. 2010 Sept;27(7):311-316